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A man suffering from TB arrives at a hospital in Mymensingh, Bangladesh.
Bangladesh has the sixth greatest TB burden in the world.
O
ne of the world’s leading killers, tuberculosis
(TB) is nearly as old as humanity itself; fos-
silized evidence of this lethal infection has been
found in a Homo erectus skeleton half a million years old. But
look to a modern hospital in a developed country, and you’d
be hard pressed to find more than a few cases. Historically,
TB is a disease of the poor. Most of the 2–3 million people
who die of the disease every year come from the developing
world or from poor, urban neighborhoods in wealthier
nations. For centuries, TB has been linked anecdotally with
environmental risk factors that go hand-in-hand with poverty:
indoor air pollution, tobacco smoke, malnutrition, over-
crowded living conditions, and excessive alcohol use. Now
scientists are presenting convincing evidence to back these
associations, leading some TB experts to argue that control
programs must confront underlying risk factors to limit the
spread of the disease.
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tion (WHO), more than 9 million new
cases of TB are diagnosed annually, 55% of
them in Asia and 31% in Africa, placing
TB second only to HIV/AIDS in terms of
the global burden of infectious disease. TB
control strategies adopted by the WHO
and other organizations emphasize clinical
solutions in the form of drugs, vaccines,
and access to health care. But despite the
success of these programs, TB incidence
and mortality aren’t falling rapidly enough
to meet WHO targets, and in some areas,
particularly in parts of Asia and throughout
sub-Saharan Africa, they continue to climb.
“Better treatment is essential, but if we
want to affect longer-term trends in the epi-
demic we will also have to deal with risk
factors,” asserts Eva Rehfuess, a scientist
with the WHO Department of Public
Health and Environment. “But doing that
won’t be easy. Social and environmental
interventions aren’t usually delivered or
funded by the health sector, so that means
we all have to work with other sectors, in par-
ticular housing, energy, and education, to
move them forward.”
Emerging evidence suggests such inter-
ventions could yield big benefits. In a
report published online 3 October 2008
ahead of print in The Lancet, Majid Ezzati
and colleagues at the Harvard School of
Public Health predict that by 2033 TB
incidence rates in parts of China could be
14–52% lower if tobacco smoking and
indoor air pollution from traditional cook-
ing stoves are eliminated. These reductions
assume that 80% of the population already
has access to optimal treatments for TB;
the benefits would be even greater among
those without such access, says Ezzati, an
associate professor of global health and
environmental health. 
The Current Situation
One-third of the world’s population is
thought to be infected with various strains
of Mycobacterium tuberculosis, the microbe
that causes TB, but only 5–10% of infected
individuals will develop active disease.
Among those with latent infections, which
are nontransmissible, M. tuberculosis exists
in a mysterious dormant state. Precisely why
the bacterium favors latency is unknown.
Immunity appears to play a role, given that
dormant TB often converts to active disease
when immune systems falter, for instance, as
a consequence of HIV/AIDS. But some TB
strains might also favor latency as an evolved
trait that fosters survival, says Christopher
Dye, an epidemiologist in the WHO Stop
TB Department and coauthor of “Expand-
ing the Global Tuberculosis Control Para-
digm: The Role of TB Risk Factors and
Social Determinants,” a chapter in the
forthcoming WHO report Priority Public
Health Conditions: From Learning to Action
on Social Determinants of Health. “It’s possi-
ble that latency evolved as a mechanism to
avoid extinction when human populations
were small and isolated,” he explains.
“There are lots of ideas, but our under-
standing of the bacteria is primitive, and we
haven’t come close to explaining the basic
facts yet.”
TB drugs are a two-edged sword, says
Tommie Victor, a professor of health sci-
ences at Stellenbosch University in South
Africa’s Western Cape Province. They
destroy the bacterium, but can also select
for resistant bacteria against which those
drugs are then ineffective. In the 1970s, the
drugs had the upper hand, and TB seemed
to be in decline. But funding and interest
in TB control programs also declined, says
Victor, and for the following 20 years no
systematic monitoring of drug resistance
was carried out. The situation changed
dramatically with the arrival of HIV/AIDS
in the 1980s, when transmission of TB and
outbreaks of multidrug-resistant (MDR)
TB increased around the globe. 
Drug-susceptible TB cases can be cured
with a standardized 6-month regimen of
first-line antibiotics administered using the
“directly observed treatment, short-course,”
or DOTS, protocol.
Under the DOTS
protocol, patients take
their daily medication
in the presence of a
health care worker to
ensure compliance.
Considered one of the
most effective clinical
programs ever, DOTS
is a cornerstone of the
WHO Stop TB Stra-
tegy, which by 2015
aims to reduce the inci-
dence of new TB cases
to 50% of 1990 levels.
(The long-term goal is
to reduce annual TB
incidence to fewer than
1 case per 1 million
people by 2050.)
When TB patients
don’t comply with
treatment, or when
they take their drugs
intermittently, resistant
bacteria survive prefer-
entially while drug-
susceptible strains die.
Thus, noncompliant
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patients diagnosed initially with
drug-susceptible TB can “acquire”
MDR TB over time. MDR TB now
accounts for 1 of every 20 new cases,
making the global TB epidemic a far
more urgent problem.
Studies by the Boston-based
Partners In Health, a nonprofit sup-
plier of health care services to devel-
oping countries, have shown MDR
TB treatments can achieve cure rates
of up to 80%. But MDR TB patients
who remain noncompliant with
treatment can acquire a still more
worrisome form of TB—dubbed
extensively drug-resistant (XDR)
TB—that resists practically every
known drug at doctors’ disposal.
This lethal disease, discovered for
the first time in 2005 in South
Africa’s KwaZulu-Natal Province, has
a far worse prognosis. This is espe-
cially true for patients coinfected
with HIV/AIDS, which blunts
the immune response and severely
exacerbates the downward spiral for
those sickened by TB. A study pub-
lished in the 7 August 2008 New
England Journal of Medicine found
that among 48 XDR TB patients in
Peru, daily supervised treatment at
community control centers achieved
cure rates of 60%. However, none of
these patients were HIV-positive.
In comparison, all but 1 of 53 HIV-
infected individuals stricken with
XDR TB in KwaZulu-Natal Province
in 2005 and 2006 died within several
weeks of developing TB symptoms. 
Other researchers have produced
particularly dire assessments of XDR
TB’s lethality. Citing results from his
survey of 4,000 TB cases across several
European countries, published in the
May 2007 issue of Emerging Infectious
Diseases, Giovanni Battista Migliori,
director of the WHO Collaborating
Centre for TB and Lung Diseases, says
XDR TB’s mortality rate is up to
5 times greater than that of MDR TB.
It was previously thought that
XDR TB, once acquired, might not
be infectious beyond hospitals and
other clinical settings. XDR TB bac-
teria were believed to be too weak to
be broadly transmissible, presumably
because the bacteria are so mutated
that they’re generally unhealthy.
Scientists have begun questioning
that assumption. Ted Cohen, an
epidemiologist and assistant professor
at Harvard Medical School, believes
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exert the so-called fitness costs that would
otherwise compromise XDR TB bacteria
and weaken them. XDR TB strains that
harbor these rare mutations, he predicts,
might survive preferentially and eventually
predominate over time, especially if more
effective drug treatments against these
strains remain elusive. Should fit strains
prevail, a nightmare scenario might fol-
low: aggressive and transmissible XDR
TB spreading inexorably through human
populations.
Given the growing global threat of TB,
the health sector is working hard to find
patients with active disease and get them on
a treatment program quickly before they
spread the disease. Indeed, active case find-
ing and improved access to health care drive
the TB agenda at organizations and institu-
tions such as the WHO and the National
Institute of Allergy and Infectious Diseases. 
But evidence shows that even more
than clinical advances, environmental
health improvements have driven historical
declines in TB prevalence. In 1979,
Thomas McKeown, a professor of social
medicine at the University of Birmingham,
United Kingdom, wrote in his book The
Role of Medicine that annual TB death
rates throughout England and Wales had
declined steadily since at least 1838, when
they approached nearly 400 per 100,000. 
By the time antibiotics and a TB vac-
cine first became widely available in the
1940s, decreased crowding, better housing,
and improved sanitation and nutrition had
pushed TB incidence in England and
Wales to fewer than 50 deaths per 100,000,
McKeown’s analysis shows. At that point,
clinical advances both augmented and
accelerated rate declines toward their cur-
rent levels. And in many parts of the devel-
oped world, TB rates still decline today. As
of 2006, the United Kingdom’s annual TB
incidence was 15 cases per 100,000 (with
935 total deaths), according to the WHO,
while the annual U.S. rate was 4 per
100,000 (with 1,310 total deaths). 
But where poverty lurks and the influ-
ence of environmental risk factors grows
(including parts of some developed nations),
TB rates soar. This is particularly true in
Africa, where HIV/AIDS is pervasive, and in
Eastern Europe, where health services have
broken down following the collapse of the
Soviet Union, the WHO reports in Global
Tuberculosis Control 2008: Surveillance,
Planning, Financing. In Russia’s over-
crowded prisons—populated largely by
young, poor people, many of whom drink
heavily—TB incidence leapt toward 5,000
cases per 100,000 during the late 1990s and
early 2000s, with mortality approaching
40% at certain points, among the highest
rates in the world, according to Salmaan
Keshavjee, an assistant professor at Harvard
Medical School. Annual TB incidence in
the rural districts surrounding Cape Town,
South Africa, where much of the popula-
tion lives in shantytowns, exceeds 1,300
cases per 100,000, says Victor. South Africa
ranks fourth on the WHO’s list of coun-
tries with the greatest TB burden, just
behind India, China, and Indonesia.
“Our TB patients are practically living
on top of each other,” observes Andreas
Diacon, a pulmonologist based at
Tygerberg Hospital, outside Stellenbosch.
“And many of them are malnourished,
HIV-positive, and prone to alcohol abuse.
Not only does crowding make it more
likely that you’ll be exposed to TB, but
substance abuse also weakens your immune
system. We have statistically more drinkers
in both our MDR and XDR populations,
and these people are also less likely to stick
with medication.” 
Confronting Environmental Risk
Factors
Those who argue in favor of risk factor
interventions say these strategies offer
broad population-level benefits. Consider
smoking cessation, says Donald Enarson,
senior advisor to the International Union
Against Tuberculosis and Lung Disease, an
independent research and outreach group
in Paris. Although its capacity to trigger
TB among individuals
is surely less than that of
HIV/AIDS, smoking
might actually trigger
more TB cases on a pop-
ulation basis because
people who smoke far
outnumber those infect-
ed with HIV, he says. 
Dye and colleagues
at the WHO Stop TB
Department, including
medical officer Knut
Lönnroth, have conducted
population-level studies of
risk factors. According to
their analyses, malnutri-
tion, indoor air pollution
from solid fuel use, and
active smoking constitute
the three top population-
attributable TB risks
globally, followed by
HIV infection, diabetes,
and excessive drinking.
The results will be pub-
lished in “Expanding the
Global Tuberculosis
Control Paradigm.” 
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factors, it’s important to distin-
guish infection risks (i.e., situa-
tions that bring people who
have TB in close contact with
others) from those that acceler-
ate disease progression among
people who are already infect-
ed. For 40 years, crowding has
been cited as a crucial infec-
tion threat in both industrial-
ized and nonindustrialized
countries. But this factor’s
unique contribution to TB risk
is hard to quantify, concedes
Lönnroth. “The relative risks
[from crowding] vary with
housing quality, TB prevalence
in the community, and also
with access to health care,
which is associated with chance
of early cure of infectious
cases,” he says.
Recent findings on crowd-
ing and TB infection risk were
published by Michael Baker
and colleagues at the He Kainga
Oranga/Housing and Health
Research Programme, Univer-
sity of Otago, New Zealand,
in the August 2008 Journal of
Epidemiology and Community
Health. The study revealed
that among those aged 40
years or younger, every 1%
increase in the proportion of
overcrowded households in a
given census block led to an
8% increase in TB incidence in that
block, holding other variables constant. 
Those results support more general
findings from India, which show that
compared with rural areas, TB prevalence
rates are consistently higher among urban
children aged 9 years or younger. Vineet
Chadha, a senior epidemiologist at the
National Tuberculosis Institute in Banga-
lore, who published those findings in
the May 2004 issue of the International
Journal of Tuberculosis and Lung Disease,
says two factors explain the urban/rural
discrepancy: first, slum conditions facili-
tate TB transmission; and second, many
urban health practitioners don’t adhere to
the DOTS protocol for TB detection and
treatment. 
The WHO agrees that poverty and
urbanization create the perfect conditions
for TB transmission. Urbanization leads to
higher population densities, crowded living
conditions, and increased mobility among
migrants seeking temporary work. 
A report on crowding and TB, created
by researchers at the University of Otago
under contract with the WHO, is expected
by the end of the year, Rehfuess says. “My
sense is that crowding is an important risk
factor, but the exposure measures used in
epidemiological studies so far haven’t been
very reliable,” she says. “So we cannot claim
to have conclusive evidence for a causal
effect yet.” She points out that many
studies show an association—the issue is
whether the association is causal or not, as
crowding tends to be associated with many
other poor socioeconomic and living condi-
tions that could confound the observed
relationship.
The links between cigarette smoking
and TB, on the other hand, are well
documented. Worldwide approximately
1.1 billion people smoke cigarettes, includ-
ing 930 million in developing or middle-
income countries, according to the WHO.
At the same time, half the world’s popula-
tion cooks on open fires or traditional
stoves fueled by coal or biomass
(wood, animal dung, crop
residues, or charcoal), often
indoors in poorly ventilated
spaces. These stoves produce
smoke with chemical con-
stituents—for example, carbon
monoxide—similar to those in
cigarette smoke. Rehfuess
points out that in the develop-
ing world most women do not
smoke, and most men do not
cook for their families. There-
fore, in these settings, smoking
is one of the greatest TB risk
factors for men, whereas indoor
air pollution from solid fuel use
is likely to be one of the greatest
for women. However, a meta-
analysis published by Ezzati’s
doctoral student Hsien-Ho Lin in
the January 2007 PLoS Medicine
suggests exposure to second-
hand tobacco smoke—not just
active smoking—also elevates
TB risk, making cigarette
smoke exposure a risk factor for
both sexes.
Since the 1940s, epidemiol-
ogists have tried to isolate the
unique contributions of tobacco
and biomass smoke to TB risk,
but early studies did not con-
trol adequately for confounders
including socioeconomic status,
nutrition, alcohol use, housing,
and crowding. A turning point
came in 2003, when Vendhan
Gajalakshmi, a scientist with the Epidemio-
logical Research Center in Chennai, India,
and colleagues published a large retro-
spective investigation that concluded half
the TB mortality among Indian men is
triggered by active tobacco smoking. This
case–control study of 43,000 male deaths
and 35,000 controls was published in the
16 August 2003 issue of The Lancet and
sparked a flurry of new investigations. 
Lin’s meta-analysis in the January 2007
PLoS Medicine and another by epidemiology
professor Michael Bates in the 26 February
2007 Archives of Internal Medicine helped
to confirm that smoke and TB are causally
linked. By combining data from dozens of
existing studies, meta-analyses reinforce
shared conclusions, Ezzati explains. “The
findings of any single study could be pro-
duced by chance, or it could show an effect
whose magnitude is smaller or larger than
the true one,” he says. “But when you
combine many studies that look at the
same question and they all point in the
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Arkadiy Yusev, age 23, is a Russian prisoner and TB patient. The dis-
ease is rampant in the overcrowded prisons of the Russian
Federation, which has the eleventh greatest TB burden in the world.same general direction, then you can have
more confidence that the conclusion
you’re getting is correct.” 
Although proposed links between
smoke exposure and TB might be more
defensible now, the underlying mechanisms
remain unclear, Ezzati concedes. According
to Lin, some scientists speculate that ciga-
rette smoke boosts TB infection risk by
impairing the ability of lung cilia to clear
bacteria from the respiratory tract. 
But exposure might also raise progres-
sion risk, adds Adrie Steyn, an assistant pro-
fessor of microbiology at The University of
Alabama at Birmingham, by flooding the
body with carbon monoxide. This gas, pro-
duced naturally by the body, helps regulate
a type of programmed cell death called
apoptosis. Evidence suggests apoptosis
might account for TB latency. But under
high carbon monoxide exposure conditions,
such as those induced by cigarette smoking
and indoor burning of biomass, apoptosis
dramatically declines, Steyn says. And that,
he concludes, might allow TB-infected cells
to survive and flourish. 
More than a matter of medical intrigue,
the effects of smoking on the infection/
progression continuum pose a real concern
for the public health response, Lin says.
“DOTS treatment acts on decreasing the
probability of infection in the population,”
he explains. “If you find that smoking acts
more on progression than infection, then
DOTS treatment and smoking cessation
might complement each other. But if
smoking is related more to infection, then
the beneficial effect of combining DOTS
with smoking cessation is smaller.”
Excessive alcohol use, meanwhile,
appears to raise progression and infection
risks alike, the former by impairing immune
responses, and the latter by inviting risky
social interactions that foster transmission of
the disease. Smoking and drinking tend to
go hand-in-hand, which makes it hard to
tease out the effect of one from the other,
says Lönnroth. He is lead author of a new
meta-analysis of 3 cohort and 18 case–con-
trol studies, produced by the WHO Stop
TB Department and published 14 August
2008 in BMC Public Health, that strives to
isolate alcohol’s role in
TB. According to that
analysis, TB risk is elevat-
ed among people who
consume more than 40
grams of alcohol per day
(the amount found in
roughly three 12-oz
glasses of beer, 5-oz
glasses of wine, or 1.5-oz
shots of hard liquor).
“Smoking was controlled
for in many but not all of
the studies in our review,
and when we separated
out the studies that con-
trolled for smoking, the
relative risk [associated
with alcohol] tended to
be even higher,” Lönn-
roth says. “The bottom
line is that both are inde-
pendent risk factors, and
together they might be
particularly strong risk
factors.”
On a population
basis, malnutrition ranks
as the risk factor most
commonly linked with
TB, according to the
forthcoming “Expanding
the Global Tuberculosis
Control Paradigm.” Still,
“the evidence [for that
association] in humans is
surprisingly thin from the perspective of
scientific rigor,” write J. Peter Cegielski
and David N. McMurray in a review of
human and animal studies published in the
March 2004 issue of the International Jour-
nal of Tuberculosis and Lung Disease. Citing
evidence from observations in humans,
work in experimental animals, and infer-
ences from related studies in other fields,
the authors note that a “wealth of ecological
associations link TB with malnutrition in
populations affected by famine, war, natural
disasters, poverty, mass migration, and con-
finement in prisons or ghettos.”
Still, human studies are problematic,
they concede, because TB itself causes wast-
ing, immune system depression, and other
symptoms resembling malnutrition. Given
that it’s usually impossible to retrospectively
discern nutritional status in patients before
their TB disease, it’s hard to determine
whether malnutrition led to TB or vice versa.
This can only be done reliably through
cohort studies that follow healthy subjects
over time after determining nutrition status
at baseline, says Lönnroth. 
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role of micronutrients, such as proteins and
vitamins. The results of such studies, Cegiel-
ski and McMurray claim, suggest that pro-
tein deficiency in particular impedes both
innate and vaccine-induced resistance to
TB, although precisely how it does so
remains unclear. The two authors conclude
that in the aggregate, evidence suggests that
malnutrition and TB are related; therefore,
“nutritional support of undernourished
populations at high risk of TB may reduce
the incidence of TB in such groups.”
Keshavjee agrees with that conclusion.
“When you’re not eating well, you’re proba-
bly not producing collagen and immune
proteins properly, and that leads to problems
with lung parenchyma [i.e., the integrity of
the lung tissue itself] and also with immune
function,” he says. “We could be talking
about something as simple as vit-
amin D deficiency. Vitamin D
helps with macrophage function,
and macrophages help to clear
TB bacteria. So if you don’t have
enough [vitamin D], you could
be at higher risk.” 
Adding to a link with nutri-
tion is growing evidence that
diabetes exacerbates TB risk. A
meta-analysis by Christie Jeon
and Megan Murray, published
15 July 2008 in PLoS Medicine,
concluded “diabetes is associat-
ed with TB risk regardless of
study design and population.”
Indeed, says Enarson, with an
increase in high-fat/low-nutrition
diets with  and lack of exercise,
the combination of diabetes
and smoking will probably
cause more TB worldwide in
the next 2 to 3 years than any
other factor.
Applying Risk Factors to
TB Control
With accumulating evidence
showing that environmental
factors exacerbate TB risk,
health experts are contem-
plating how to incorporate
these findings into TB control
programs. For a start, says
Rehfuess, health professionals
should inform patients and
their families of the potential
harm resulting from excessive
drinking, smoking, indoor bio-
mass burning, and other prac-
tices. “Raising awareness and
creating demand for solutions
will not solve the problem,” she says, “but
it could be a stepping stone. And even that
is not happening.” 
Murray and others suggest that high-
risk populations, including smokers and
diabetic patients, might be targeted for
active case finding. Locating patients with
TB remains a difficult challenge. The dis-
ease can take weeks to diagnose; mean-
while, untreated patients pose infection
risks to their communities. Looking within
high-risk populations might make those
efforts more efficient. Moreover, tying case
detection to enticements such as improved
cooking stoves might also make for good
strategy, Ezzati proposes. “Those who
agree to be tested for TB regularly, along
with those who agree to quit smoking,
might be entitled to a clean stove benefit,”
Ezzati says. “And that would have benefits
beyond TB, because these pollutants also
increase risks for other lung diseases.” 
Partners In Health has already incorpo-
rated risk factors into their treatment
approach, Keshavjee says. The organization
supports community treatment programs
and helps families pay to build an additional
room to house the infected patient, thereby
reducing the risk of crowding, while also
supplying clean fuels such as kerosene to
reduce indoor air pollution. Keshavjee
concedes these measures come at a cost to
the organization, but he emphasizes the
downstream expenses posed by inade-
quately treated TB are far higher. 
Thus far, the WHO hasn’t integrated
risk factors into its TB control efforts. The
problem, Dye points out, is that changes in
the risk factor trends that have traditionally
accompanied TB fluctuations occur slowly—
over decades or even centuries.
“Smoke exposure and other fac-
tors heighten TB risk, but it’s
difficult to imagine how we
could manipulate these things to
bring down TB incidence
quickly,” he says. “It would be
beneficial if these risk factors did-
n’t exist, but they’re not going to
replace prompt drug treatment,
which is still the most powerful
way to save lives quickly and
reduce transmission. Risk factor
interventions are useful, but
they’re supplementary.” 
Still, the authors of “Expand-
ing the Global Tuberculosis
Control Paradigm” acknowledge
that “even if the Stop TB strategy
is successfully implemented . . .
the global incidence rate by 2050
would be about 100 times greater
than the elimination target. Inter-
ventions to reduce progression to
disease may include preventive
treatment with anti-TB drugs, a
new vaccine that prevents progres-
sion from infection to disease, as
well as reducing exposure to vari-
ous social, environmental, and
biological risk factors for TB.”
Adds Keshavjee, “[Environmen-
tal] risk factor controls have not
typically been under the purview
of the TB community. To address
them, we have to think outside
the box.”
Charles W. Schmidt
A typographic error in the original version of
this article miscited the duration of the DOTS
regimen. The error has been corrected here. 
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For many TB patients, such as this terminally ill woman in Kinshasa,
DR Congo, effective drugs are prohibitively expensive. DR Congo
has the tenth greatest TB burden in the world. 